Immune PET Imaging

被引：3
作者：
Iyalomhe, Osigbemhe [1 ]
Farwell, Michael D. [1 ]
机构：
[1] Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
RADIOLOGIC CLINICS OF NORTH AMERICA | 2021年 / 59卷 / 05期
基金：
美国国家卫生研究院;
关键词：
Immunotherapy; Immune-related adverse events; FDG; PET/CT; Immune imaging; METASTATIC MELANOMA PATIENTS; RESPONSE CRITERIA; F-18-FDG PET/CT; PD-1; BLOCKADE; CHECKPOINT INHIBITOR; ANTITUMOR IMMUNITY; CLINICAL-RESPONSE; TUMOR RESPONSE; ADVERSE EVENTS; CANCER;
D O I：
10.1016/j.rcl.2021.05.010
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：875 / 886
页数：12
相关论文
共 101 条
[1]   Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress? [J].
Adashek, Jacob J. ;
Kato, Shumei ;
Ferrara, Roberto ;
Lo Russo, Giuseppe ;
Kurzrock, Razelle .
ONCOLOGIST, 2020, 25 (02) :94-98
[2]   FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature [J].
Aide, Nicolas ;
Hicks, Rodney J. ;
Le Tourneau, Christophe ;
Lheureux, Stephanie ;
Fanti, Stefano ;
Lopci, Egesta .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (01) :238-250
[3]   Imaging activated T cells predicts response to cancer vaccines [J].
Alam, Israt S. ;
Mayer, Aaron T. ;
Sagiv-Barfi, Idit ;
Wang, Kezheng ;
Vermesh, Ophir ;
Czerwinski, Debra K. ;
Johnson, Emily M. ;
James, Michelle L. ;
Levy, Ronald ;
Gambhir, Sanjiv S. .
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (06) :2569-2580
[4]   PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].
Ansell, Stephen M. ;
Lesokhin, Alexander M. ;
Borrello, Ivan ;
Halwani, Ahmad ;
Scott, Emma C. ;
Gutierrez, Martin ;
Schuster, Stephen J. ;
Millenson, Michael M. ;
Cattry, Deepika ;
Freeman, Gordon J. ;
Rodig, Scott J. ;
Chapuy, Bjoern ;
Ligon, Azra H. ;
Zhu, Lili ;
Grosso, Joseph F. ;
Kim, Su Young ;
Timmerman, John M. ;
Shipp, Margaret A. ;
Armand, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319
[5]   Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab [J].
Anwar, Hoda ;
Sachpekidis, Christos ;
Winkler, Julia ;
Kopp-Schneider, Annette ;
Haberkorn, Uwe ;
Hassel, Jessica C. ;
Dimitrakopoulou-Strauss, Antonia .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (03) :376-383
[6]   Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [J].
Armand, Philippe ;
Engert, Andreas ;
Younes, Anas ;
Fanale, Michelle ;
Santoro, Armando ;
Zinzani, Pier Luigi ;
Timmerman, John M. ;
Collins, Graham P. ;
Ramchandren, Radhakrishnan ;
Cohen, Jonathon B. ;
De Boer, Jan Paul ;
Kuruvilla, John ;
Savage, Kerry J. ;
Trneny, Marek ;
Shipp, Margaret A. ;
Kato, Kazunobu ;
Sumbul, Anne ;
Farsaci, Benedetto ;
Ansell, Stephen M. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1428-+
[7]   The value of18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis [J].
Ayati, Narjess ;
Sadeghi, Ramin ;
Kiamanesh, Zahra ;
Lee, Sze Ting ;
Zakavi, S. Rasoul ;
Scott, Andrew M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (02) :428-448
[8]   89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer [J].
Bensch, Frederike ;
van der Veen, Elly L. ;
Lub-de Hooge, Marjolijn N. ;
Jorritsma-Smit, Annelies ;
Boellaard, Ronald ;
Kok, Iris C. ;
Oosting, Sjoukje F. ;
Schroder, Carolina P. ;
Hiltermann, T. Jeroen N. ;
van der Wekken, Anthonie J. ;
Groen, Harry J. M. ;
Kwee, Thomas C. ;
Elias, Sjoerd G. ;
Gietema, Jourik A. ;
Bohorquez, Sandra Sanabria ;
de Crespigny, Alex ;
Williams, Simon-Peter ;
Mancao, Christoph ;
Brouwers, Adrienne H. ;
Fine, Bernard M. ;
de Vries, Elisabeth G. E. .
NATURE MEDICINE, 2018, 24 (12) :1852-+
[9]   Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis [J].
Bertrand, Anne ;
Kostine, Marie ;
Barnetche, Thomas ;
Truchetet, Marie-Elise ;
Schaeverbeke, Thierry .
BMC MEDICINE, 2015, 13
[10]  
Billan S, 2020, LANCET ONCOL, V21, pE463, DOI 10.1016/S1470-2045(20)30328-4
12345678910